drugset / Trial / NCT00457405

Does a Seven Day Treatment With Dipyridamole Induce Protection Against Ischemia-Reperfusion Injury?

NCT00457405

Phase 4 Completed 10 enrolled Radboud University Medical Center
RandomizedCrossoverQuadruple-blindTreatment

Summary

This study is performed to determine whether a seven day treatment with dipyridamole (slow release, 200mg twice daily) can induce a protective effect against ischemia-reperfusion injury, after ischemic exercise of the non-dominant forearm in healthy volunteers.

Timeline

Start
2007-06
Primary completion
2007-10
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dipyridamole Other / unclassified 200 mg